Screening Failure H Sample Clauses

Screening Failure H. Neúspěšný screening

Screening Failure H. NEÚSPEŠNÉ VSTUPNÉ VYŠETRENIA Reimbursement for screen failures will be paid at the amounts in EURO currency, which are indicated on the Screening Visit of the attached budget table, not to exceed one (1) screen failure(s) paid per one (1) subject(s) randomized. Úhrady za neúspešné vstupné vyšetrenia sa budú poukazovať v peňažných sumách v mene EUR, ktoré sú uvedené v skríningovej návšteve priloženej v rozpočtovej tabuľke a neprekročí jeden (1) neuspešné vstupné vyšetrenie zaplatené za jedného randomizovaného pacienta. To be eligible for reimbursement of a screening visit, completed screening CRF pages must be submitted to IQVIA along with any additional information, which may be requested by IQVIA to appropriately document the subject screening procedures. Aby vznikol nárok na úhradu za vstupnú návštevu, je potrebné zaslať spoločnosti IQVIA vyplnené stránky CRF pre vstupné vyšetrenia všetky ďalšie informácie, ktoré môže spoločnosť IQVIA požadovať, aby dostatočne zdokumentovala vstupné vyšetrenia subjektu. I. STUDY START-UP FEE A one-time, non-refundable payment will be paid to the Institution in the amount of 800 EUROS (€) to cover Study start-up activities upon completion and receipt by IQVIA of all contractual and regulatory documentation and receipt ofinvoice. J. Patient Medication (Cholestyramine or Activated Charcoal) costs for the purpose of the Accelerated Elimination of Teriflunomide, will be reimbursed, where needed, on a pass-through basis upon receipt of supporting invoices from Institution, up to One Hundred Euro (€100) [ to be paid per patient]. Patient numbers and procedure date must be included on the invoice.